Printer Friendly

VISION-SCIENCES, INC. FILES WITH SEC FOR INITIAL PUBLIC OFFERING

 VISION-SCIENCES, INC. FILES WITH SEC FOR INITIAL PUBLIC OFFERING
 NATICK, Mass., Nov. 9 /PRNewswire/ -- Vision-Sciences, Inc. today announced the filing of a registration statement with the Securities and Exchange Commission related to the proposed initial public offering of 2,550,000 shares of common stock. Of these shares, 2,500,000 are being offered by the company and 50,000 shares are being offered by a stockholder. It is currently anticipated that the initial public offering price will be between $7 and $9 per share. The company expects to have approximately 9.7 million shares outstanding after the offering.
 Kidder, Peabody & Co. Incorporated will manage the offering. A copy of the preliminary prospectus can be obtained from Kidder, Peabody & Co. Incorporated, 10 Hanover Square, New York, N.Y. 10005.
 In addition, Vision-Sciences, Inc. has granted to the underwriters an option to purchase up to an additional 382,500 shares of common stock to cover over-allotments, if any.
 Vision-Sciences' business strategy is to develop, manufacture and market infection control products for endoscopy, a minimally invasive technique for medical screening, diagnosis and therapy. The company has recently received FDA clearance to market the following products: (1) A proprietary sterile disposable sheath, known as an Endosheath, for use with its ENT endoscope -- used for viewing the ears, nose and larynx; and (2) a disposable Endosheath/reusable flexible sigmoid oscope system -- for viewing the colon. These products are designed to eliminate the risk to patients of infection from contaminated endoscopes.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
 -0- 11/9/92
 /CONTACT: David W. Prigmore, president of Vision-Sciences, Inc., 508-650-9971/ CO: Vision Sciences ST: Massachusetts IN: HEA SU: OFR


TS -- NY017 -- 8531 11/09/92 09:07 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1992
Words:373
Previous Article:GENSIA REPORTS THIRD QUARTER RESULTS
Next Article:$2.43 MILLION TRUCK SIMULATOR CONTRACT AWARDED TO PERCEPTRONICS AND FAAC JOINT VENTURE
Topics:


Related Articles
COATING SCIENCES FILES INITIAL PUBLIC OFFERING OF COMMON STOCK
TOUCHSTONE APPLIED SCIENCE ASSOCIATES COMPLETES INITIAL PUBLIC OFFERING
DATA RACE ANNOUNCES FILING WITH SEC FOR INITIAL PUBLIC OFFERING
VISION-SCIENCES, INC. ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK AT $9 PER SHARE
Vision Sciences Reports Strong Finish to Fiscal Year, With Record Quarterly Revenues and Near Break-Even Net Income
Cardiac Science's Acquisition of Survivalink and Artema on Course to Close By End of September.
Special Meeting of Cardiac Science Stockholders Regarding Proposed Merger With Quinton Cardiology Systems Scheduled for August 31, 2005.
SAIC Plans to Offer Shares to the Public.
Applied Precision Files Registration Statement With the SEC for an Initial Public Offering.
China Automotive Systems, Inc.: the case for reverse mergers.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters